Christian Rommel

Christian Rommel

Chief Tech/Sci/R&D Officer at BAYER AG

Net worth: - $ as of 31/05/2026

59 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Christian Rommel is an Independent Director at CRISPR Therapeutics AG and an EVP, Head-Research & Development at Bayer AG.
He is on the Board of Directors at CRISPR Therapeutics AG, AskBio Inc. and Vividion Therapeutics, Inc. Dr. Rommel was previously employed as a SVP, Head-Oncology Research & Early Development by F.
Hoffmann-La Roche Ltd., a Chief Scientific Officer by Intellikine LLC, a VP-External Research & Development by Amgen, Inc., a Head-Target Research by Merck Serono Ltd., and a Senior Scientist by Regeneron Pharmaceuticals, Inc. He received his undergraduate degree from the University of Greifswald and a doctorate degree from the Max-Planck-Institute for Molecular Genetics.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/06/2026 0 ( -.--% ) - $ 31/05/2026

Christian Rommel active positions

CompaniesPositionStart
BAYER AG Chief Tech/Sci/R&D Officer 01/02/2021
CRISPR THERAPEUTICS AG Director/Board Member 13/03/2024
Director/Board Member -
Director/Board Member -

Former positions of Christian Rommel

CompaniesPositionEnd
Corporate Officer/Principal 01/02/2021
Chief Tech/Sci/R&D Officer 01/12/2012
AMGEN INC. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
REGENERON PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Christian Rommel's experience

Training of Christian Rommel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

38

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Christian Rommel
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!